Bugworks, which is headquartered in the U.S. with subsidiaries in India and Australia, specializes in the development of antibiotics that could address the growing crisis of antimicrobial resistance.
When German scientists posted data in 2022 showing that CAR-T cell therapy could be effective in treating systemic lupus erythematosus, interest in the field quickly took off. More recently, spurring ...
As 2024 comes to a close, and while we will soon be thinking about 2025 and the trends that will shape the biotech industry, now is a good time to look back at what happened this year. Earlier this ...
The integration of artificial intelligence (AI) in the biotech industry seems boundless. Its combination with CRISPR could be the one area where AI has the most potential. Nobel prize winner and ...
Asking whether China is the future of the biotech industry might seem counterintuitive, considering the current biotech geopolitical context. If you haven’t followed this series of events, a ...